Skip to content
Search AI Powered

Latest Stories

Blunt Take: Athletic Cannabis Bans and the Big Pharma Influence

Is Big Pharma behind WADA's cannabis ban? Probably.
Is Big Pharma behind WADA's cannabis ban? Probably.
Image by Gerhard from Pixabay

The World Anti-Doping Agency (WADA) has kept cannabis on its list of banned substances for 2023.

The list was finalized on Sept 23.


According to the Wall Street Journal, “WADA’s Prohibited List Expert Advisory Group has backed keeping a ban in place, saying that based on the scientific evidence available, the drug meets the criteria for inclusion on the list.”

WADA, which handles athletic drug testing for the Olympics and other sports, was urged by the U.S. Anti-Doping Agency last year to review its approach to cannabis after the controversial suspension of American sprinter Sha’Carri Richardson last year.

Richardson was suspended from participating in the Tokyo games after previously consuming cannabis in Oregon, where the plant has been medically legal since 1998 and legal for all adults since 2014.

In response to the outcry, WADA promised to initiate a scientific review of cannabis and is now leaning toward a continued ban.

But why? What scientific evidence did they review exactly?

What’s the concern with athletes using cannabis as part of their regimen?

Is Weed a Performance-Enhancing Substance?

The whole point of WADA’s existence is to prevent cheaters from spoiling the competition.

This message is loud and clear on the homepage of their website: “Raising the game for clean sport.”

Do they then consider cannabis as a performance enhancer? What other reason to ban it?

It’s not uncommon to hear of creatives getting dialed in at work with just the right dose of cannabinoids, or athletes enjoying invigorated exercise routines with improved recovery time thanks to cannabis’s anti-inflammatory properties.

Or what about athletes governed under WADA’s policies who could use cannabis to help with sleep, stress, and anxiety?

This doesn’t sound like a performance-enhancing drug at all because an optimized cannabis regimen is all about restoring balance and harmony to the body and the mind.

Imagine if WADA banned nutritional supplements. Imagine if they banned meditation. Sounds extreme right? Or what if they banned antidepressants or anti-inflammatories?

What’s wrong with an athlete who can learn how to use cannabis to take better care of themselves and maybe even improve the longevity of their career?

Frankly, this is a win-win scenario unless you’re Big Pharma still trying to peddle pill-shaped solutions.

The Big Pharma Factor

WADA’s Prohibited List Expert Advisory Group is heavily comprised of people who come from Big Pharma.

You can double check the group members over at WADA’s website for yourself. Even group chair Dr. Audrey Kinahan has a robust background in the pharmaceutical industry.

What’s more, they don’t consider cannabis a performance enhancer at all. It’s just a banned substance. In fact, athletes can get a Therapeutic Use Exemption (TUE) for it.

It’s no secret that Big Pharma has a vested interest in cannabis prohibition.

Over the years, Big Pharma has actively played a role in slowing cannabis progress through legislative lobbying (aka legalized bribery) and the funding of anti-cannabis propaganda.

Why would people want pills with harsh side effects when the right amount of cannabis at the right time seems to do a better job?

It was recently reported that the pharmaceutical industry is losing billions to the cannabis space, and they’re no doubt scratching and clawing out of sheer self-preservation.

When you consider how the industry’s business model relies on people getting or staying sick, how can you trust anything with their fingerprints on it?

Banning and Testing for THC is Problematic and Unfair

WADA’s continued ban of cannabis shows how little they care about science or the health of athletes.

“The problem with the testing of ‘marijuana’ (or THC) versus other substances is the duration of time in which is it detectable,” said Codi Peterson, Chief Science Offer at The Cannigma.

“Many drugs are long gone compared to THC metabolites which can linger for a while.”

In other words, weed can stay in your system for a long time, and you can still fail a drug test even if you haven’t consumed any THC for a few days, or sometimes longer.

And even then, does it really make sense to be testing for THC/cannabis in the first place?

“It’s cruel to expect athletes to perform for others’ entertainment, and not allow them to recover with humane treatments. WADA is shameful,” said Mara Gordon, founder of Aunt Zelda’s, which has helped thousands of chronically ill patients and their doctors integrate medical cannabis regimens into conventional treatment protocols.

Diana McElroy, a lifestyle wellness coach and yoga instructor also chimed in with her experience. “Cannabis is a medicine and helps people with inflammation and body aches. Athletes in particular benefit greatly.”

Of course, WADA will need more than just anecdotal reports to make an informed decision to lift the ban on cannabis.

But what info are they looking for exactly, other than Big Pharma stock ratings?

Need a little more Bluntness in your life? Subscribe for our newsletter to stay in the loop.

More For You

Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Giphy

Aging & Cannabis: New Findings

For decades, cannabis has been widely regarded as a substance with potential cognitive risks, particularly when used over long periods. Governments across the globe have classified it as a controlled substance, citing concerns about the effects of marijuana use, including memory loss, diminished executive function, and long-term neurological impact. But new research is challenging this long-standing assumption, suggesting that cannabis use may not be linked to age-related cognitive decline—and might even be associated with better cognitive preservation over time.

A recent study published in PubMed (NIH, 2024) followed over 5,000 men for more than four decades to analyze the long-term cognitive effects of cannabis use. The results? Men with a history of cannabis use experienced less cognitive decline from early adulthood to late midlife compared to those who never used cannabis.

Keep ReadingShow less
a crudely rolled lit joint being passed to camera
Photo by Chase Fade on Unsplash

Alcohol vs Marijuana: Alcohol Worse?

Turns out, your friend who swapped tequila shots for THC gummies might be on to something. A new poll has found that a majority of Americans now believe alcohol is more harmful to a person’s health than marijuana—and frankly, it’s about time. The severe health risks associated with alcohol use, including addiction, various diseases, and a high incidence of mortality, are becoming more widely recognized.

The survey, conducted by YouGov, asked over 1,000 U.S. adults to weigh in on which substance does more damage: good ol’ booze or that plant that’s still somehow federally illegal. The verdict? 64% of respondents said alcohol is more dangerous, compared to just 27% who pointed the finger at weed. The rest? They couldn’t decide or didn’t care enough to pick.

Keep ReadingShow less
image of a circle of doctors and surgeons standing over and looking at a patient on operating room table
New Study Confirms Medical Cannabis Benefits in Cancer Care—Time for Policy to Catch Up
Photo by National Cancer Institute on Unsplash

Cannabis & Cancer: The Evidence Is In—So Why Is the Medical Establishment Still Dragging Its Feet?

If you've ever watched a loved one battle cancer—or been on that journey yourself—you already know the harsh truth: the pain is real, the nausea is relentless, the appetite is gone, and the side effects of treatment often feel worse than the disease. So when patients say cannabis helps, it shouldn’t take 10,000 studies for the medical community to take them seriously.

And yet, here we are.

Keep ReadingShow less
Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness
Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness
Photo by Axel Antas-Bergkvist on Unsplash

Kanye West Is Spiraling—And Our Mental Health System Is Letting It Happen - The Bluntness

Kanye West, aka Ye, isn’t just trending—he’s unraveling in real time. And instead of intervention, we get viral clips, condemnation, and an audience watching a man self-destruct. His latest stunt? Airing a Super Bowl ad promoting a swastika-emblazoned Yeezy shirt on his site—a move so blatantly antisemitic that even the most die-hard supporters had to step back. This act garnered significant media coverage, leading to brands cutting ties and agents dropping him. His social media account faced scrutiny and was ultimately deleted after a history of controversial postings. But here’s the problem: canceling Kanye doesn’t fix Kanye.

At this point, the question isn’t whether his actions are inexcusable (they are). The question is, what happens when one of the world’s most influential figures is also one of the most untreated cases of mental illness in pop culture history?

Keep ReadingShow less
Diverse mix of people sitting outdoors, around a table smiling at camera
Hall of Flowers 2025: Why This Santa Rosa Showcase Remains a Standard Bearer for Cannabis Trade Shows
Press photo provided by Hall of Flowers

Hall of Flowers 2025: Cannabis Trade Show Leader

The cannabis industry has no shortage of events, but very few manage to balance business, culture, and community the way Hall of Flowers does. Since its launch in 2018, the Santa Rosa-based show has become a must-attend gathering for licensed brands, retailers, investors, and innovators.

This year’s edition takes place September 10–11, 2025, at the Sonoma County Fairgrounds, continuing a legacy that goes far beyond trade show floor traffic. Hall of Flowers has become a barometer for where cannabis is now and where it's heading—and how brands and buyers can stay ahead of the curve.

Keep ReadingShow less